Dudediligence.

Palvella Therapeutics, Inc

PVLANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$6.8MSep ’24−$4.0MDec ’24−$8.2MMar ’25−$9.5MJun ’25−$11.3MSep ’25−$12.7MDec ’25−$15.8MMar ’26−$21.9MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025Jun 2026
Revenue$25.5M$38.7Mnone on filenone on filenone on file
Operating income−$43.5M−$11.9M−$14.1M−$38.6Mnone on file
Net income−$33.3M$18.7M−$17.4M−$41.7Mnone on file
Operating cash flow−$59.9M−$13.7M−$10.8M−$25.0Mnone on file
Free cash flow−$61.0M−$13.9Mnone on filenone on filenone on file
Cash$38.6M$7.3M$83.6M$58.0M$187.8M
Shares outstanding74.5M1.8M11.0M12.4M14.4M